Healthy subjects
Conditions
Interventions
Single ingestion of test food >
single ingestion of placebo food.
Single ingestion of placebo food >
Sponsors
R&D Institute Morinaga & Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy males and females aged over 18 to under 30 when informed consent. (2) Subjects who first language is Japanese. (3) Subjects who have received enough explanation and understood about this study, and who can obtain informed consent documents. (4) Subjects who are able to come to the measurement facility on the designated measurement date and take the measurement.
Exclusion criteria
Exclusion criteria: Subjects who 1)fasting blood glucose of 126 mg/dL or higher 2)have chronic physical illness 3)have or are being treated for memory impairment disease symptoms such as dementia 4)have alcoholism or other mental disorders 5)currently have some kind of disease and are receiving drug treatment 6)have received any kind of drug treatment(except for a history of abortive medication such as headache, menstrual cramps, common cold, etc.)for one month prior to obtaining consent 7) have currently, or within the past 3 months, continuously using drugs that claim to maintain or enhance cognitive function 8)have currently, or within the past 3 months have been, or will be during the study period, continuously consuming functional foods, health foods, or supplements that claim to maintain or enhance cognitive function 9)have undergone medical treatment involving hospitalization within the past 6 months, or those who are scheduled to be hospitalized during the examination period 10)have current medical history or past medical history of serious disease in heart, liver, kidney, digestive organ 11)who have been diagnosed with iron deficiency anemia by a physician or determined to have iron deficiency anemia by medical examination or other means 12)may develop seasonal allergic symptoms such as hay fever during the study period 13) have food allergies (including a history of food allergies) (especially milk and gelatin) 14)Pregnant, lactating, or possibly pregnant, or planning to become pregnant during the study period 15)Subjects with smoking habit 16)may change their lifestyle during the study period (drastic change in club activities, long trips, etc.) 19)currently participating in another clinical trial, or one month has not passed since participation in another clinical trial 22)were judged ineligible for enrollment in the study by the principal investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of brain activity (objective and subjective evaluations) | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety Assessment (adverse events and side effects) | — |
Countries
Japan
Contacts
Public ContactYuko Matsui
Morinaga & Co., Ltd Health Science and Research Center, R&D institute
Outcome results
None listed